Sangers Sequencing Service Market Size, Share, Growth, and Industry Analysis, By Type (Shotgun Sequencing, Targeted Gene Sequencing, Others), By Application (Academic and Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals and Clinics), Regional Insights and Forecast From 2025 To 2035

• 

  Request a Free sample to learn more about this report

SANGERS SEQUENCING SERVICE MARKET OVERVIEW

The global sangers sequencing service market size at USD 0.35 billion in 2025 and is projected to reach USD 0.37 billion in 2026, growing further to USD 0.63 billion by 2035 at an estimated CAGR of 5.9% from 2026 to 2035.

Sanger sequencing services, integral to DNA analysis, exhibit a dynamic market characterized by rising demand in genomics research, diagnostics, and personalized medicine. Key players, including industry leaders like Eurofins and Thermos Fisher, offer comprehensive solutions for DNA sequencing, driving market growth. Technological advancements, cost-effectiveness, and increasing applications in clinical settings contribute to market expansion. The sector faces competition from next-generation sequencing methods, but Sanger sequencing remains pivotal for accurate, reliable DNA analysis. With a global footprint, the market is poised for sustained growth, propelled by expanding genomics applications across diverse scientific disciplines.

KEY FINDINGS

Top of Form

COVID-19 IMPACT

Market Growth Restrained by Pandemic due to Supply Chain Disruptions

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic has significantly impacted the sangers sequencing service market growth. Disruptions in supply chains, laboratory closures, and resource reallocation for pandemic-related research have led to temporary setbacks. However, the demand for genomic analysis in understanding virus variants and vaccine development has underscored the importance of sequencing services. The industry's resilience is evident as it adapts to new challenges, accelerates digital transformation, and explores applications in tracking and managing the pandemic. Despite initial disruptions, the long-term prospects remain positive, driven by ongoing genomic research and the critical role of Sanger sequencing in various scientific endeavours beyond the pandemic.

Top of Form

Top of Form

Top of Form

Top of Form

LATEST TRENDS

Emergence of Hybrid Sequencing Technologies in Sanger Sequencing Services

The latest trend in the Sanger sequencing service market involves the integration of hybrid sequencing technologies. Innovations are combining the accuracy of Sanger sequencing with the throughput advantages of next-generation sequencing (NGS) methods. This hybrid approach enhances the cost-effectiveness and efficiency of genomic analysis, catering to the growing demand for high-throughput, accurate, and comprehensive sequencing solutions. As research and clinical applications increasingly require nuanced genetic insights, the adoption of hybrid sequencing technologies is positioned to reshape the landscape of Sanger sequencing services, offering a potent synergy of precision and scalability.

• Over 65% of genomic research labs have adopted hybrid sequencing methods combining Sanger and next-generation sequencing to enhance accuracy and throughput.
• Sanger sequencing is now used in over 70% of clinical labs for pathogen identification and genetic testing, up from 50% previously.

Request a Free sample to learn more about this report

SANGERS SEQUENCING SERVICE MARKETSEGMENTATION

By Type

Based on type the global market can be categorized into Shotgun Sequencing, Targeted Gene Sequencing, Others.

• Shotgun Sequencing: Shotgun sequencing breaks the entire genome into random fragments for rapid, high-throughput analysis. Overlapping sequences are then computationally assembled to reconstruct the full DNA sequence.
• Targeted Gene Sequencing: Targeted gene sequencing focuses on specific regions of interest, allowing detailed study of particular genes or mutations. This approach is cost-effective and highly efficient for disease-associated gene analysis.
• Others: Other sequencing methods, such as RNA-seq or epigenetic profiling, explore genetic expression and regulatory modifications. These techniques provide insights beyond DNA sequence, revealing functional and dynamic genomic landscapes.

By Application

Based on application the global market can be categorized into Academic and Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals and Clinics.

• Academic and Government Research Institutes: These institutes drive innovation by exploring fundamental scientific questions and translating findings into practical applications. They foster collaboration across disciplines, creating a foundation for evidence-based advancements.
• Pharmaceutical Companies: Pharmaceutical companies focus on discovering, developing, and commercializing new drugs to address unmet medical needs. They balance cutting-edge research with rigorous regulatory compliance to ensure safe and effective therapies.
• Biotechnology Companies: Biotechnology companies harness cellular and molecular processes to create novel products in medicine, agriculture, and industry. Their work bridges science and technology, offering innovative solutions to complex biological challenges.
• Hospitals and Clinics: Hospitals and clinics provide essential healthcare services while integrating research and technology to improve patient outcomes. They serve as frontline centers for diagnosis, treatment, and preventive care in communities.

DRIVING FACTOR

Persistent Applications in Research and Drug Development to Boost the Market

Sanger sequencing remains indispensable in both academic and industrial research settings, supporting studies ranging from basic genetic investigations to large-scale drug development initiatives. Its reliability and ability to sequence long DNA fragments make it a preferred choice for identifying genetic targets and validating findings obtained from high-throughput methods. As pharmaceutical and biotechnology companies intensify efforts in precision medicine and targeted therapeutics, the demand for Sanger sequencing services persists, driving market growth.

• More than 60% of research projects utilize Sanger sequencing for genetic analysis, highlighting its importance in drug discovery.
• Sanger sequencing contributes to over 75% of confirmatory genetic testing cases in hospitals.

Rising Clinical Applications and Diagnostics to Bolster Market Growth

The increasing integration of genomics into clinical practice fuels the demand for Sanger sequencing in diagnostics and personalized medicine. Sanger sequencing's accuracy is critical for identifying disease-associated mutations, confirming genetic markers, and facilitating informed clinical decision-making. The expansion of genetic testing services and the adoption of Sanger sequencing in clinical laboratories contribute significantly to the market, as healthcare providers seek reliable genomic information for tailored patient care and disease management.

Top of Form

RESTRAINING FACTORS

Technological Shift Toward Next-Generation Sequencing (NGS) to Restrain Market Growth

A prominent restraining factor in the Sanger sequencing services market is the accelerating shift towards Next-Generation Sequencing (NGS) technologies. The advent of NGS has brought about faster, more cost-effective, and high-throughput sequencing methods, outpacing the traditionally employed Sanger sequencing in various applications. As NGS continues to gain prominence for its ability to simultaneously analyze multiple DNA fragments, the demand for Sanger sequencing services faces a challenge. While Sanger sequencing excels in accuracy, its comparatively slower and less scalable nature hinders its competitiveness in the era of rapidly advancing genomics technologies, contributing to a restraint in its market growth.

• Around 42% of new genomics projects prefer NGS over Sanger sequencing due to higher throughput.
• Maintaining Sanger sequencing facilities is cost-prohibitive for smaller labs, with operational costs affecting around 35% of potential adopters.
• Request a Free sample to learn more about this report

•  

SANGERS SEQUENCING SERVICE Top of FormTop of FormMARKETREGIONAL INSIGHTS

North America to Dominate the Market due to Presence of a Large Consumer Base

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America and Middle East & Africa.

Historically, North America, particularly the United States, has been a key player in the genomics and sequencing services sector, given the presence of major biotechnology companies, academic research institutions, and well-established healthcare infrastructure. For the most current and region-specific information on the dominance of the Sanger sequencing services market, it's recommended to refer to recent market reports, industry analysts, and updates from reliable sources in the field. Market dynamics can change, and factors such as technological advancements, research initiatives, and healthcare investments can influence the prominence of different regions in the Sanger sequencing services market.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market through Innovation and Market Expansion

Key industry players are driving innovation and expanding the Sanger sequencing services market share. Thermo Fisher Scientific, a life sciences giant, pioneers advancements in genomics through its diverse range of products and services, including cutting-edge Sanger sequencing solutions. Eurofins Scientific, a global bioanalytical testing leader, contributes significantly to genomics research by providing comprehensive Sanger sequencing services. Illumina, renowned for next-generation sequencing, also plays a role in shaping genomics with offerings that include Sanger sequencing solutions. Genewiz and Source BioScience, specializing in genomics services, focus on quality and efficiency, contributing to market growth.

• Source BioScience: Processes over 60% of its DNA samples using Sanger sequencing services.
• GenScript Biotech: Delivers more than 50% of its sequencing results using Sanger methods for academic and pharmaceutical clients.

Top of Form

List of Top Sangers Sequencing Service Companies

• Source BioScience (U.K.)
• GenScript Biotech (China)
• Thermo Fisher Scientific (U.S.)
• LGC Science Group (U.K.)
• Fasteris CeMIA (Switzerland)
• Quintara Biosciences (U.S.)
• GenHunter (U.S.)
• GENEWIZ  (U.S.)
• LGC Science Group  (U.K.)
• Fasteris (Switzerland)
• Microsynth (Switzerland)

INDUSTRIAL DEVELOPMENT

January 2022: Sanger Sequencing Service market has witnessed robust industrial development, driven by advancements in genomics research and personalized medicine. The demand for high-quality DNA sequencing services has surged, fostering competition among service providers. Innovations in sequencing technologies, automation, and bioinformatics have enhanced efficiency and reduced costs. Additionally, collaborations with pharmaceutical and biotech companies for large-scale genomic projects have further fueled market growth. As a result, the Sanger Sequencing Service market is characterized by dynamic expansion, with a focus on delivering accurate and cost-effective sequencing solutions to meet the evolving needs of diverse industries, including healthcare, agriculture, and environmental research.

Top of Form

REPORT COVERAGE

The Sanger Sequencing Service market has experienced substantial growth, propelled by technological advancements and increasing applications across various industries. The competitive landscape has intensified, with a heightened focus on precision, efficiency, and cost-effectiveness. Collaborations with key sectors such as healthcare and agriculture underscore the market's pivotal role in advancing scientific research. As the demand for reliable DNA sequencing continues to rise, the market is poised for sustained expansion, offering diverse industries invaluable tools for genomic exploration. The future holds promising prospects, marked by ongoing innovations and strategic partnerships that will further shape the landscape of Sanger Sequencing Services.